NorstellaLinQ: Complex Cohort Identification Fuels Real-Time HCP Targeting
MMIT’s NorstellaLinQ integrates structured and unstructured real-world data (RWD) to help oncology manufacturers identify complex cohorts in real time. By combining diagnostic codes, lab results, and NLP-driven clinical note analysis, pharma companies can reach prescribing physicians earlier in the treatment journey.
Advanced Patient Identification
Use diagnostic codes, lab results, and unstructured EMR data to surface hard-to-find patients.
Cohort Segmentation
Stratify patients by disease progression, tumor grading, and other clinical factors.
Physician Targeting at Scale
Deliver timely insights to prescribing physicians through weekly, customized data pulls.